Your browser doesn't support javascript.
loading
AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia.
Yi, Xue; Sarkar, Aloke; Kismali, Gorkem; Aslan, Burcu; Ayres, Mary; Iles, LaKesla R; Keating, Michael J; Wierda, William G; Long, James P; Bertilaccio, Maria Teresa Sabrina; Gandhi, Varsha.
Afiliación
  • Yi X; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sarkar A; Department of Hematology, Wuhan No. 1 Hospital, Wuhan, Hubei, China.
  • Kismali G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Aslan B; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ayres M; Department of Biochemistry, Ankara University Faculty of Veterinary Medicine, Ankara, Turkey.
  • Iles LR; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Keating MJ; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wierda WG; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Long JP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bertilaccio MTS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gandhi V; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(14): 3856-3867, 2020 07 15.
Article en En | MEDLINE | ID: mdl-31937611

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína 1 de la Secuencia de Leucemia de Células Mieloides / Naftalenos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína 1 de la Secuencia de Leucemia de Células Mieloides / Naftalenos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article